| iPSC-Derived Cholinergic Neurons | |
|---|---|
| Lineage | Stem Cell > iPSC > Cholinergic |
| Markers | CHAT, VAChT, SLC18A3 |
| Brain Regions | In Vitro |
| Disease Relevance | Alzheimer's Disease, Myasthenia Gravis |
iPSC-derived cholinergic neurons are specialized neurons generated from induced pluripotent stem cells (iPSCs) that exhibit the molecular and functional properties of endogenous basal forebrain cholinergic neurons. These cells provide a crucial in vitro model for studying Alzheimer's disease (AD) pathogenesis, drug discovery, and cell replacement therapy development[1].
Differentiation of iPSCs into cholinergic neurons typically follows a staged protocol that mimics embryonic forebrain development:
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000108 | cholinergic neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000108 | cholinergic neuron | Medium |
iPSC-derived cholinergic neurons express the following canonical markers:
| Marker | Function | Detection Method |
|---|---|---|
| CHAT | Acetylcholine synthesis | Immunohistochemistry, qPCR |
| VAChT | Vesicular acetylcholine transporter | Immunohistochemistry |
| SLC18A3 | Vesicular transporter | RNA-seq |
| p75NTR | Neurotrophin receptor | Flow cytometry |
| TrkA | NGF receptor | Western blot |
Single-cell RNA sequencing studies have identified distinct subtypes of iPSC-derived cholinergic neurons that correspond to medial septum, diagonal band, and nucleus basalis populations in vivo[3].
Mature iPSC-derived cholinergic neurons exhibit:
iPSC-derived cholinergic neurons from AD patients demonstrate:
These neurons can be used to model autoimmune-mediated cholinergic dysfunction and test therapeutic interventions targeting acetylcholine receptor antibodies.
iPSC-derived cholinergic neurons enable screening for:
While still experimental, iPSC-derived cholinergic neurons hold promise for:
Conditioned media from iPSC-derived cholinergic neurons can provide insights into:
| Property | iPSC-Derived | Primary (Rodent) | Primary (Human) |
|---|---|---|---|
| Availability | Unlimited | Limited | Very Limited |
| Genetic Background | Patient-specific | Inbred | Variable |
| Maturation Time | 6-10 weeks | 2-4 weeks | N/A |
| Cholinergic Purity | 60-80% | Variable | Variable |
Induced pluripotent stem cells: A new tool for disease modeling and drug discovery in neurodegenerative diseases (Nature Reviews Drug Discovery, 2023). 2023. ↩︎
Directed differentiation of human pluripotent stem cells into basal forebrain cholinergic neurons (Cell Stem Cell, 2022). 2022. ↩︎
Single-cell transcriptomic analysis of human iPSC-derived cholinergic neurons reveals diversity in disease states (Neuron, 2024). 2024. ↩︎
Cholinergic deficits in iPSC-derived neurons from Alzheimer's disease patients (Acta Neuropathologica, 2023). 2023. ↩︎